P1187: END OF TREATMENT 18F FDG‐PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION‐FREE SURVIVAL IN PERIPHERAL T‐CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO‐T TRIAL PET/CT SUBSTUDY.

Autor: Gleeson, M., Arias, C., Cunningham, D., Peckitt, C., Du, Y., Hujairi, N., To, Y. M., Chen, H.‐C., Patel, S., Chau, I., Johnson, P., Ardeshna, K. M., Wotherspoon, A., Attygalle, A., Hawkes, E. A., Macheta, M. P., Collins, G. P., Radford, J., Forbes, A., Hart, A.
Zdroj: HemaSphere; 2022 Supplement 3, Vol. 6, p1073-1074, 2p
Databáze: Complementary Index
Externí odkaz: